Design of Synthesizable PROTACs through Synthesis Constrained Generative Model and Reinforcement Learning

  • JACS Au. 2026 Jul 7;6(7):4239-4252. doi: 10.1021/jacsau.6c00732.
Mingyuan Xu  1  2 Chaoming Huang  3 Li Pang  4  5 Qirui Deng  1 Hao Zhang  1 Anjie Qiao  6 Zhiwen Luo  4  5 Zhen Wang  6 Chang-Yu Hsieh  7 Zhang Zhang  3 Tie-Gen Chen  4  5 Hongming Chen  2  8 Jinping Lei  1
Affiliations
  • 1. State Key Laboratory of Anti-Infective Drug Discovery and Development, Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Science, Sun Yat-sen University, Guangzhou 510006, China.
  • 2. Guangzhou National Laboratory, No. 9 Xing Dao Huan Bei Road, Guangzhou International Bio Island, Guangzhou 510005, China.
  • 3. State Key Laboratory of Bioactive Molecules and Druggability Assessment, International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Discovery of Chinese Ministry of Education, Guangzhou City Key Laboratory of Precision Chemical Drug Development, School of Pharmacy, Jinan University, Guangzhou 510632, China.
  • 4. Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China.
  • 5. Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • 6. School of Computer Science and Engineering, Sun Yat-sen University, Guangzhou 510006, China.
  • 7. College of Pharmaceutical Sciences and Cancer Center, Zhejiang University, Hangzhou 310058, Zhejiang China.
  • 8. Guangzhou Medical University, Guangzhou 511495, China.
Abstract

Proteolysis targeting chimeras (PROTACs) have emerged as a promising technology in degrading disease-related proteins for drug design. Recent deep generative models can accelerate PROTAC design, but the generated molecules are often difficult to synthesize. Here, we develop the SynPROTAC model, which integrates chemical reaction path-driven molecule assembly with reinforcement learning for the design of synthesizable PROTACs together with favorable binding properties. Specifically, the synthesis-constrained generative model employs a Graph Transformer-encoded warhead or E3 ligand as input and autoregressively samples reaction templates and building blocks through transformer-based decoder for PROTAC construction. The comprehensive evaluations indicated that SynPROTAC is capable of generating new PROTACs with feasible synthetic routes and reasonable physicochemical and binding-related properties. We further applied SynPROTAC to design PROTAC molecules degrading bromodomain-containing protein 4 (BRD4), and two selected compounds were successfully synthesized according to the synthetic routes proposed by SynPROTAC. In the following biological experiments, both of them exhibited nanomolar-level degradation activity against BRD4 and potent antiproliferation activity against MV411 tumor cells. These results demonstrate the capability of SynPROTAC to design novel bioactive PROTAC molecules with feasible synthesis routes.

Keywords
Generative model; PROTAC design; Synthesizable; reinforcement learning; transformer.
Products